"Located in Phoenixville, PA, Phoenixville Hospital is a 144-bed facility that provides comprehensive medical services through emergency room visits, inpatient admissions, outpatient procedures and community outreach programs. Phoenixville Hospital’s services include an award-winning cardiovascular program, a fully accredited cancer center, NAPBC-accredited breast health center, an acute inpatient rehabilitation center, and a large robotic surgery center. Phoenixville Hospital is accredited by The Joint Commission and has been recognized for its quality outcomes and clinical expertise across services lines that include joint replacement surgery, advanced heart failure care, and the designation as a Primary Stroke Center."

During the past decade, Phoenixville Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Phoenixville Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Eastern Cooperative Oncology Group" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Phoenixville Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Phoenixville Hospital" are "Breast Cancer" (6 trials), "Breast Adenocarcinoma" (4 trials), "Recurrent Breast Carcinoma" (4 trials), "Breast Carcinoma" (3 trials) and "Plasma Cell Myeloma" (3 trials). Many other conditions were trialed in "Phoenixville Hospital" in a lesser frequency.

Most popular intervention types in "Phoenixville Hospital" are "Other" (30 trials), "Drug" (29 trials), "Biological" (11 trials), "Procedure" (7 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (12 trials), "Paclitaxel" (8 trials), "Carboplatin" (6 trials) and "Bevacizumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Phoenixville Hospital" are 24 trials for "All" genders and 15 trials for "Female" genders.

Currently, there are NaN active trials in "Phoenixville Hospital". undefined are not yet recruiting, 5 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Phoenixville Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Phoenixville Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".